塔塔纪念中心癌症核医学诊断和治疗模式的循证应用。

IF 0.9 4区医学 Q4 ONCOLOGY

Indian journal of cancer Pub Date : 2024-01-01 Epub Date: 2024-03-01 DOI:10.4103/ijc.ijc_52_24

Ameya D Puranik, Sayak Choudhury, Suchismita Ghosh, Indraja D Dev, Varun Ramchandani, Abhishek Uppal, Vikrant Bhosale, Abhishek Palsapure, Rachita Rungta, Rakesh Pandey, Shweta Khatri, Gemson George, Yogesh Satamwar, Rahul Maske, Archi Agrawal, Sneha Shah, Nilendu C Purandare, Venkatesh Rangarajan

{"title":"塔塔纪念中心癌症核医学诊断和治疗模式的循证应用。","authors":"Ameya D Puranik, Sayak Choudhury, Suchismita Ghosh, Indraja D Dev, Varun Ramchandani, Abhishek Uppal, Vikrant Bhosale, Abhishek Palsapure, Rachita Rungta, Rakesh Pandey, Shweta Khatri, Gemson George, Yogesh Satamwar, Rahul Maske, Archi Agrawal, Sneha Shah, Nilendu C Purandare, Venkatesh Rangarajan","doi":"10.4103/ijc.ijc_52_24","DOIUrl":null,"url":null,"abstract":"Abstract: PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it's way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology.","PeriodicalId":13505,"journal":{"name":"Indian journal of cancer","volume":"61 Suppl 1","pages":"S1-S28"},"PeriodicalIF":0.9000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer.\",\"authors\":\"Ameya D Puranik, Sayak Choudhury, Suchismita Ghosh, Indraja D Dev, Varun Ramchandani, Abhishek Uppal, Vikrant Bhosale, Abhishek Palsapure, Rachita Rungta, Rakesh Pandey, Shweta Khatri, Gemson George, Yogesh Satamwar, Rahul Maske, Archi Agrawal, Sneha Shah, Nilendu C Purandare, Venkatesh Rangarajan\",\"doi\":\"10.4103/ijc.ijc_52_24\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract: PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it's way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology.\",\"PeriodicalId\":13505,\"journal\":{\"name\":\"Indian journal of cancer\",\"volume\":\"61 Suppl 1\",\"pages\":\"S1-S28\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian journal of cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.4103/ijc.ijc_52_24\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/3/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4103/ijc.ijc_52_24","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/3/1 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

摘要：PET/CT 和放射性同位素治疗分别是核医学的诊断和治疗手段。随着更先进技术的出现，PET/CT 已成为一种可及的模式。探索疾病特异性靶点的诊断示踪剂使临床医生的目光不再局限于 FDG PET。此外，随着放射性药物治疗对的出现，放射性同位素疗法正逐渐进入印度常见癌症的治疗算法中。因此，我们希望详细讨论 PET/CT 成像和放射性核素治疗的最新进展，并编写一份以共识为导向的循证文件，为肿瘤学从业人员提供指导。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer.

Abstract: PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it's way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Indian journal of cancer Medicine-Oncology

CiteScore

1.40

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Indian Journal of Cancer (ISSN 0019-509X), the show window of the progress of ontological sciences in India, was established in 1963. Indian Journal of Cancer is the first and only periodical serving the needs of all the specialties of oncology in India.

塔塔纪念中心 癌症核医学诊断和治疗模式的循证应用。

摘要

塔塔纪念中心癌症核医学诊断和治疗模式的循证应用。